Konishi Tomoko, Tsuda Tatsuya, Sakaguchi Yoshiko, Imai Yasutomo, Ito Takashi, Hirota Seiichi, Yamanishi Kiyofumi
Department of Dermatology, Hyogo College of Medicine, Nishinomiya, Japan.
J Dermatol. 2014 Mar;41(3):258-61. doi: 10.1111/1346-8138.12410. Epub 2014 Feb 10.
Netherton syndrome (NS) is a rare autosomal recessive disorder which is caused by mutations in the SPINK5 gene encoding the serine-protease inhibitor LEKTI. Characteristic symptoms of NS include erythroderma with diffuse desquamation, hair abnormalities and atopic manifestations. Here, we report two Japanese patients with NS, one of whom had a novel mutation in the SPINK5 gene which leads to p.C367Lfs*3. The upregulation of interleukin-33 (IL-33) was evident in basal and thickened lower spinous layers of the epidermis in those cases. This suggests that IL-33 may be involved in the pathophysiology of NS as well as in atopic dermatitis.
Netherton综合征(NS)是一种罕见的常染色体隐性疾病,由编码丝氨酸蛋白酶抑制剂LEKTI的SPINK5基因突变引起。NS的特征性症状包括伴有弥漫性脱屑的红皮病、毛发异常和特应性表现。在此,我们报告两名日本NS患者,其中一名患者的SPINK5基因发生了新的突变,导致p.C367Lfs*3。在这些病例中,白细胞介素-33(IL-33)在表皮基底和增厚的棘层下部明显上调。这表明IL-33可能参与了NS以及特应性皮炎的病理生理过程。